CEST Imaging of Nose-to-Brain Drug Delivery using Iohexol liposomes at 3T

Research output: Conference PapersAbstractpeer-review

View graph of relations

Detail(s)

Original languageEnglish
Publication statusPublished - May 2021

Conference

Title2021 International Society for Magnetic Resonance in Medicine (ISMRM) & Society for MR Radiographers & Technologists (SMRT) Annual Meeting
LocationOnline
Period15 - 20 May 2021

Abstract

Image guided nose-to-brain drug delivery provides a non-invasive monitoring of drug delivery to the brain, which increases effective dose via bypassing Blood Brain Barrier(BBB). Here, we investigated the imaging of nanomedicine delivery via intranasal administration using CEST-detectable mucus penetrating liposome(with 10%PEG). Liposomes were loaded with Iohexol(Ioh-Lipo) and CEST properties both in-vitro and in-vivo were examined by injecting into the mouse nostril. Ioh-Lipo generated CEST contrast of 33.4% at 4.3 ppm in vitro. This specific CEST contrast was observed in the nostril, olfactory bulb and the frontal lobe after intranasal administration at 3T. We demonstrated the liposomes detectability both in nostril and olfactory bulb by CEST. The result demonstrates a robust approach for imaging-guided Nose-to-Brain Intranasal Liposomal Drug Delivery.

Citation Format(s)

CEST Imaging of Nose-to-Brain Drug Delivery using Iohexol liposomes at 3T. / LAW, Lok Hin; XIAO, Peng; Huang, Jianpan et al.
2021. Abstract from 2021 International Society for Magnetic Resonance in Medicine (ISMRM) & Society for MR Radiographers & Technologists (SMRT) Annual Meeting.

Research output: Conference PapersAbstractpeer-review